PRE (n = 5) | s-PRE (n = 5) | SEVO (n = 5) | s-SEVO (n = 5) | PPF (n = 5) | s-PPF (n = 5) | p-value | |
---|---|---|---|---|---|---|---|
Operation duration (min) | 314 ± 49 | 326 ± 82 | 219 ± 54 | 321 ± 82 | 227 ± 43 | 288 ± 108 | 0.089 |
Anesthesia duration (min) | 370 ± 52 | 400 ± 87 | 279 ± 50 | 380 ± 85 | 290 ± 42 | 347 ± 109 | 0.102 |
Cardiopulmonary bypass duration (min) | 171 ± 38 | 177 ± 61 | 111 ± 37 | 163 ± 51 | 107 ± 11 | 125 ± 33 | 0.036 |
Aorta cross-clamp duration (min) | 130 ± 44 | 111 ± 49 | 85 ± 30 | 109 ± 52 | 72 ± 7 | 83 ± 29 | 0.193 |
Type of cardioplegia | 0.004 | ||||||
HTK solution | 5 (100%) | 3 (60%) | 1 (20%) | 1 (20%) | 0 (0%) | 0 (0%) | |
Del Nido | 0 (0%) | 2 (40%) | 4 (80%) | 4 (80%) | 5 (100%) | 5 (100%) | |
Total dosage of cardioplegia (L) | 4.0 (4.0–4.5) | 3.0 (1.5–4.5) | 2.0 (1.1–3.0) | 1.3 (1.2–4.4) | 1.2 (1.0–1.8) | 1.2 (1.0–1.8) | 0.037 |
Nadir nasal temperature (°C) | 27.6 ± 1.7 | 29.2 ± 1.8 | 29.4 ± 2.0 | 29.6 ± 2.9 | 30.6 ± 1.8 | 29.3 ± 2.6 | 0.388 |
Nadir rectal temperature (°C) | 29.1 ± 2.0 | 29.9 ± 1.5 | 30.8 ± 0.6 | 30.1 ± 3.0 | 31.8 ± 0.8 | 30.5 ± 2.4 | 0.266 |
Intraoperative RBC transfusion (unit) | 0 (0–0 [0–0]) | 0 (0–0 [0–0]) | 0 (0–1 [0–1]) | 0 (0–1 [0–1]) | 0 (0–0 [0–1]) | 0 (0–0 [0–2]) | 0.477 |
Intraoperative FFP transfusion (unit) | 0 (0–2 [0–3]) | 3 (2–3 [0–3]) | 2 (0–3 [0–3]) | 0 (0–3 [0–3]) | 0 (0–0 [0–0]) | 0 (0–3 [0–3]) | 0.271 |
Intraoperative plateletpheresis transfusion (unit) | 0 (0–0 [0–1]) | 1 (0–1 [0–1]) | 0 (0–1 [0–2]) | 0 (0–1 [0–2]) | 0 (0–0 [0–0]) | 0 (0–0 [0–1]) | 0.425 |
Postoperative RBC transfusion (unit) | 2 (1–2 [0–5]) | 2 (1–3 [0–8]) | 0 (0–0 [0–5]) | 2 (0–2 [0–3]) | 0 (0–1 [0–2]) | 1 (0–3 [0–4]) | 0.507 |
Postoperative FFP transfusion (unit) | 0 (0–2 [0–4]) | 1 (0–2 [0–3]) | 0 (0–0 [0–4]) | 0 (0–0 [0–1]) | 0 (0–0 [0–1]) | 0 (0–1 [0–1]) | 0.626 |
Postoperative plateletpheresis transfusion (unit) | 1 (0–1 [0–2]) | 2 (1–2 [0–6]) | 0 (0–0 [0–1]) | 0 (0–0 [0–3]) | 0 (0–0 [0–1]) | 0 (0–1 [0–2]) | 0.194 |
Peak postoperative troponin I within 72 h (ng/mL) | 9.31 (7.38–38.51) | 24.92 (6.95–185.85) | 4.31 (2.61–19.93) | 13.35 (4.21–92.68) | 6.69 (3.48–7.93) | 6.18 (4.61–27.01) | 0.317 |
Postoperative atrial fibrillation | 0 (0%) | 1 (20%) | 1 (20%) | 1 (20%) | 2 (40%) | 1 (20%) | 0.974 |
Re-exploration | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | N/A |
In-hospital stroke | 0 (0%) | 0 (0%) | 1 (20%) | 1 (20%) | 0 (0%) | 0 (0%) | 0.509 |
In-hospital myocardial infarction | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | N/A |
In-hospital mortality | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | N/A |